Ignite Creation Date:
2024-05-06 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05169801
Status:
COMPLETED
Last Update Posted:
2021-12-27
First Post:
2021-12-23
Brief Title:
To Compare the Efficacy and Safety of BP102 vs Avastin in Combination With PaclitaxelCarboplatin in First-line Treatment of Advanced or Relapsed NSCLC
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Organization Data
Organization:
Jiangsu HengRui Medicine Co Ltd
Class:
INDUSTRY
Study ID:
HR-BP102-III-NSCLC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jiangsu HengRui Medicine Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None